Dealing with the Verteporfin Shortage: Treatment Options and Outcomes in Patients with Chronic and Non-Resolving Central Serous Chorioretinopathy
During the shortage of verteporfin, a different treatment strategy was applied, with HD-PDT being performed less frequently. By implementing a more patient-tailored approach, the VA and the resolution rate of SRF remained similar to the year before the shortage.
Authors
- Franca C. Hartgers
- Suzanne Yzer (ORCID: https://orcid.org/0000-0002-1069-8380)
- Carel B. Hoyng (ORCID: https://orcid.org/0000-0002-1358-5963)
- Femke M. van den Tillaart (ORCID: https://orcid.org/0000-0002-0583-2450)
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- Radboud Institute for Molecular Life Sciences (NL)
Publication Details
- Journal
- Ophthalmologica
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1159/000542224
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Stichting Steunfonds Uitzicht
- Oogfonds
- Algemene Nederlandse Vereniging ter voorkoming van Blindheid
- Landelijke Stichting voor Blinden en Slechtzienden
- Stichting Blinden-Penning